[HTML][HTML] Discrete choice experiments in health economics: past, present and future

V Soekhai, EW de Bekker-Grob, AR Ellis, CM Vass - Pharmacoeconomics, 2019 - Springer
Abstract Objectives Discrete choice experiments (DCEs) are increasingly advocated as a
way to quantify preferences for health. However, increasing support does not necessarily …

[HTML][HTML] Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR conjoint analysis good research practices task force

AB Hauber, JM González, CGM Groothuis-Oudshoorn… - Value in health, 2016 - Elsevier
Conjoint analysis is a stated-preference survey method that can be used to elicit responses
that reveal preferences, priorities, and the relative importance of individual features …

[HTML][HTML] Incidental findings with genomic testing: implications for genetic counseling practice

MI Roche, JS Berg - Current genetic medicine reports, 2015 - Springer
This paper summarizes the current controversies surrounding the identification and
disclosure of “incidental” or “secondary” findings from genomic sequencing and the …

[HTML][HTML] A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology

LELM Vissers, KJ Van Nimwegen, JH Schieving… - Genetics in …, 2017 - nature.com
Purpose: Implementation of novel genetic diagnostic tests is generally driven by
technological advances because they promise shorter turnaround times and/or higher …

[PDF][PDF] The clinical sequencing evidence-generating research consortium: integrating genomic sequencing in diverse and medically underserved populations

LM Amendola, JS Berg, CR Horowitz, F Angelo… - The American Journal of …, 2018 - cell.com
The Clinical Sequencing Evidence-Generating Research (CSER) consortium, now in its
second funding cycle, is investigating the effectiveness of integrating genomic (exome or …

[PDF][PDF] Clinical sequencing exploratory research consortium: accelerating evidence-based practice of genomic medicine

RC Green, KAB Goddard, GP Jarvik… - The American Journal of …, 2016 - cell.com
Despite rapid technical progress and demonstrable effectiveness for some types of
diagnosis and therapy, much remains to be learned about clinical genome and exome …

[HTML][HTML] Toward the diagnosis of rare childhood genetic diseases: what do parents value most?

S Pollard, D Weymann, J Dunne, F Mayanloo… - European Journal of …, 2021 - nature.com
Genomic testing is becoming routine for diagnosing rare childhood genetic disease.
Evidence underlying sustainable implementation is limited, focusing on short-term endpoints …

[HTML][HTML] The personal utility and uptake of genomic sequencing in pediatric and adult conditions: eliciting societal preferences with three discrete choice experiments

I Goranitis, S Best, J Christodoulou, Z Stark… - Genetics in …, 2020 - Elsevier
Purpose To estimate the personal utility and uptake of genomic sequencing (GS) across
pediatric and adult-onset genetic conditions. Methods Three discrete choice experiment …

[HTML][HTML] Valuation of health and nonhealth outcomes from next-generation sequencing: approaches, challenges, and solutions

DA Regier, D Weymann, J Buchanan, DA Marshall… - Value in Health, 2018 - Elsevier
Background Next-generation sequencing (NGS) technologies have seen variable adoption
in the clinic. This is partly due to a lack of clinical and economic studies, with the latter …

[HTML][HTML] Do solidarity and reciprocity obligations compel African researchers to feedback individual genetic results in genomics research?

D Ralefala, M Kasule, A Wonkam, M Matshaba… - BMC medical …, 2020 - Springer
Background A key ethical question in genomics research relates to whether individual
genetic research results should be disclosed to research participants and if so, which results …